All CF samples were derived from patients with at least one class II CFTR mutation resulting in amino acid deletions and missense mutations that lead to the production of an abundance of misfolded mutant CFTR protein, so UPR would therefore be expected. The gene discussed is CFTR; the disease is cystic fibrosis.